Avivomed
Avivomed is a company dedicated to developing neuromodulation therapies aimed at addressing significant unmet clinical needs. The organization focuses on the commercialization of innovative neuromodulation technology platforms that target chronic diseases, providing medical professionals with advanced tools to enhance patient care. By concentrating on next-generation therapies, Avivomed seeks to improve treatment options for individuals suffering from various chronic health conditions, ultimately fostering better health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.